You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
23 March 2020
RETRANSMISSION: COVID-19 Test and Development Programs Update
20 March 2020
XPhyto Announces COVID-19 Test and Development Programs Update
19 March 2020
XPhyto Therapeutics Epilepsy Treatment Program
3 March 2020
XPhyto Therapeutics Initiates Infectious Disease Programs
18 February 2020
Exclusive Strategic Partnership Commenced Between XPhyto Therapeutics and Elite Bavarian Brewing & Beverage Institute Weihenstephan
27 January 2020
XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market
9 December 2019
Epilepsy Treatment to Be Developed with XPhyto Therapeutics’ Oral Thin Film Delivery System
6 December 2019
XPhyto Therapeutics Developing Epilepsy Treatment with Oral Thin Film Delivery System
25 November 2019
XPhyto Therapeutics Pharmaceutical-Grade Cannabis Extraction Lab
12 November 2019
Xphyto Therapeutics Oral and Transdermal Cannabis Delivery and Dosage Systems
4 November 2019
XPhyto Therapeutics Signs Term Sheet for German Cannabis Distribution
19 September 2019
XPhyto Therapeutics Engages Global Cannabis Expert for German Operations
9 September 2019
XPhyto Therapeutics Signs Exclusive German Cannabis Agreement with Elite Bavarian Brewing & Beverage Institute
26 August 2019
XPhyto Therapeutics to Acquire German Narcotics Company
14 August 2019
XPhyto Therapeutics Enters Exclusive Cannabis Research and Development Agreement with the Technical University of Munich
13 August 2019
XPhyto Therapeutics Commences Trading on the Frankfurt Stock Exchange
6 August 2019
XPhyto Therapeutics Commences Trading on the CSE
